{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T17:55:58Z","timestamp":1787594158654,"version":"build-2736575974"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T00:00:00Z","timestamp":1623628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T00:00:00Z","timestamp":1623628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The novel SS18-SSX fusion-specific antibody is reported to have high sensitivity and specificity for the diagnosis of primary synovial sarcoma (SS), which often metastasizes to the lung. Thus far, no study has validated the diagnostic efficacy of SS18-SSX antibody for pulmonary metastatic SS. Therefore, we aimed to investigate the usefulness of the SS18-SSX antibody in the diagnosis of pulmonary metastatic SS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We evaluated the immunohistochemistry of SS18-SSX fusion-specific antibody (E9X9V) in 10 pulmonary metastatic SS cases and the corresponding five primary sites (four limbs and one mediastinum) in five patients, for whom SS was already diagnosed and confirmed by fluorescence in-situ hybridization in the metastatic and primary sites, and in 93 clinical and histologic mimics including 49 non-SS, pulmonary metastatic sarcomas, 39 primary lung cancers, and five intrathoracic solitary fibrotic tumors. All specimens were surgically resected at Shinshu University Hospital during 2001\u20132019. For primary and metastatic SS, we also evaluated SS18-SSX immunohistochemistry using needle biopsy and touch imprint cytology specimens from the primary site.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>SS18-SSX staining was diffusely-strongly positive in all 10 pulmonary metastatic SS cases and the corresponding five primary sites; whereas, it was negative in all 93 clinical and histologic mimics (100% sensitivity and 100% specificity). Further, SS18-SSX staining was also sufficiently positive in the biopsy and cytology specimens.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Immunohistochemistry of the SS18-SSX fusion-specific antibody is useful for the differential diagnosis of pulmonary metastatic SS in clinical practice. This simple and reliable method has the potential to replace traditional genomic tests. However, further studies are warranted in this regard.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13000-021-01110-6","type":"journal-article","created":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T17:02:32Z","timestamp":1623690152000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Usefulness of SS18-SSX antibody as a diagnostic marker for pulmonary metastatic synovial sarcoma"],"prefix":"10.1186","volume":"16","author":[{"given":"Kentaro","family":"Miura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimihiro","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Eguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachie","family":"Koike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunichiro","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsu","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutoshi","family":"Hamanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Uehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,14]]},"reference":[{"issue":"1","key":"1110_CR1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/COC.0b013e31823fe450","volume":"36","author":"W Shi","year":"2013","unstructured":"Shi W, Indelicato DJ, Morris CG, Scarborough MT, Gibbs CP, Zlotecki RA. Long-term treatment outcomes for patients with synovial sarcoma: a 40-year experience at the University of Florida. Am J Clin Oncol. 2013;36(1):83\u20138. https:\/\/doi.org\/10.1097\/COC.0b013e31823fe450.","journal-title":"Am J Clin Oncol"},{"issue":"15","key":"1110_CR2","doi-asserted-by":"publisher","first-page":"3537","DOI":"10.1002\/cncr.24424","volume":"115","author":"I Sultan","year":"2009","unstructured":"Sultan I, Rodriguez-Galindo C, Saab R, Yasir S, Casanova M, Ferrari A. Comparing children and adults with synovial sarcoma in the surveillance, epidemiology, and end results program, 1983 to 2005: an analysis of 1268 patients. Cancer. 2009;115(15):3537\u201347. https:\/\/doi.org\/10.1002\/cncr.24424.","journal-title":"Cancer."},{"issue":"6","key":"1110_CR3","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.anndiagpath.2014.09.002","volume":"18","author":"K Thway","year":"2014","unstructured":"Thway K, Fisher C. Synovial sarcoma: defining features and diagnostic evolution. Ann Diagn Pathol. 2014;18(6):369\u201380. https:\/\/doi.org\/10.1016\/j.anndiagpath.2014.09.002.","journal-title":"Ann Diagn Pathol"},{"issue":"7","key":"1110_CR4","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1097\/PAS.0000000000001447","volume":"44","author":"E Baranov","year":"2020","unstructured":"Baranov E, McBride MJ, Bellizzi AM, Ligon AH, Fletcher CDM, Kadoch C, et al. A novel SS18-SSX fusion-specific antibody for the diagnosis of synovial sarcoma. Am J Surg Pathol. 2020;44(7):922\u201333. https:\/\/doi.org\/10.1097\/PAS.0000000000001447.","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"1110_CR5","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1002\/(SICI)1097-0142(19990615)85:12<2596::AID-CNCR16>3.0.CO;2-K","volume":"85","author":"P Bergh","year":"1999","unstructured":"Bergh P, Meis-Kindblom JM, Gherlinzoni F, Berlin O, Bacchini P, Bertoni F, et al. Synovial sarcoma: identification of low and high risk groups. Cancer. 1999;85(12):2596\u2013607. https:\/\/doi.org\/10.1002\/(SICI)1097-0142(19990615)85:12<2596::AID-CNCR16>3.0.CO;2-K.","journal-title":"Cancer."},{"issue":"4","key":"1110_CR6","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.jpedsurg.2012.09.042","volume":"48","author":"EJ Stanelle","year":"2013","unstructured":"Stanelle EJ, Christison-Lagay ER, Wolden SL, Meyers PA, La Quaglia MP. Pulmonary metastasectomy in pediatric\/adolescent patients with synovial sarcoma: an institutional review. J Pediatr Surg. 2013;48(4):757\u201363. https:\/\/doi.org\/10.1016\/j.jpedsurg.2012.09.042.","journal-title":"J Pediatr Surg"},{"issue":"5","key":"1110_CR7","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1097\/JTO.0b013e3182106f5c","volume":"6","author":"JD Predina","year":"2011","unstructured":"Predina JD, Puc MM, Bergey MR, Sonnad SS, Kucharczuk JC, Staddon A, et al. Improved survival after pulmonary metastasectomy for soft tissue sarcoma. J Thorac Oncol. 2011;6(5):913\u20139. https:\/\/doi.org\/10.1097\/JTO.0b013e3182106f5c.","journal-title":"J Thorac Oncol"},{"issue":"22","key":"1110_CR8","doi-asserted-by":"publisher","first-page":"3794","DOI":"10.1200\/JCO.2000.18.22.3794","volume":"18","author":"AJ Spillane","year":"2000","unstructured":"Spillane AJ, A'Hern R, Judson IR, Fisher C, Thomas JM. Synovial sarcoma: a clinicopathologic, staging, and prognostic assessment. J Clin Oncol. 2000;18(22):3794\u2013803. https:\/\/doi.org\/10.1200\/JCO.2000.18.22.3794.","journal-title":"J Clin Oncol"},{"issue":"6","key":"1110_CR9","doi-asserted-by":"publisher","first-page":"451","DOI":"10.5090\/kjtcs.2016.49.6.451","volume":"49","author":"K Lee","year":"2016","unstructured":"Lee K, Kang MC, Lee HW, Park JH, Baek HJ, Cho SJ, et al. Pulmonary metastasectomy in adult patients with synovial sarcoma: a single-center experience. Korean J Thorac Cardiovasc Surg. 2016;49(6):451\u20135. https:\/\/doi.org\/10.5090\/kjtcs.2016.49.6.451.","journal-title":"Korean J Thorac Cardiovasc Surg"},{"issue":"7","key":"1110_CR10","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s10147-019-01422-0","volume":"24","author":"Y Yamamoto","year":"2019","unstructured":"Yamamoto Y, Kanzaki R, Kanou T, Ose N, Funaki S, Shintani Y, et al. Long-term outcomes and prognostic factors of pulmonary metastasectomy for osteosarcoma and soft tissue sarcoma. Int J Clin Oncol. 2019;24(7):863\u201370. https:\/\/doi.org\/10.1007\/s10147-019-01422-0.","journal-title":"Int J Clin Oncol"},{"issue":"1","key":"1110_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/1098-2264(2000)9999:9999<::AID-GCC1056>3.0.CO;2-G","volume":"30","author":"NR dos Santos","year":"2001","unstructured":"dos Santos NR, de Bruijn DR, van Kessel AG. Molecular mechanisms underlying human synovial sarcoma development. Genes Chromosom Cancer. 2001;30(1):1\u201314. https:\/\/doi.org\/10.1002\/1098-2264(2000)9999:9999<::AID-GCC1056>3.0.CO;2-G.","journal-title":"Genes Chromosom Cancer"},{"issue":"1","key":"1110_CR12","first-page":"135","volume":"62","author":"M Ladanyi","year":"2002","unstructured":"Ladanyi M, Antonescu CR, Leung DH, Woodruff JM, Kawai A, Healey JH, et al. Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients. Cancer Res. 2002;62(1):135\u201340.","journal-title":"Cancer Res"},{"issue":"4","key":"1110_CR13","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1111\/his.14190","volume":"77","author":"M Zaborowski","year":"2020","unstructured":"Zaborowski M, Vargas AC, Pulvers J, Clarkson A, de Guzman D, Sioson L, et al. When used together SS18-SSX fusion-specific and SSX C-terminus immunohistochemistry are highly specific and sensitive for the diagnosis of synovial sarcoma and can replace FISH or molecular testing in most cases. Histopathology. 2020;77(4):588\u2013600. https:\/\/doi.org\/10.1111\/his.14190.","journal-title":"Histopathology."},{"issue":"5","key":"1110_CR14","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1097\/00000478-200105000-00007","volume":"25","author":"M Miettinen","year":"2001","unstructured":"Miettinen M, Limon J, Niezabitowski A, Lasota J. Calretinin and other mesothelioma markers in synovial sarcoma: analysis of antigenic similarities and differences with malignant mesothelioma. Am J Surg Pathol. 2001;25(5):610\u20137. https:\/\/doi.org\/10.1097\/00000478-200105000-00007.","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"1110_CR15","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1038\/modpathol.2009.47","volume":"22","author":"K Kosemehmetoglu","year":"2009","unstructured":"Kosemehmetoglu K, Vrana JA, Folpe AL. TLE1 expression is not specific for synovial sarcoma: a whole section study of 163 soft tissue and bone neoplasms. Mod Pathol. 2009;22(7):872\u20138. https:\/\/doi.org\/10.1038\/modpathol.2009.47.","journal-title":"Mod Pathol"},{"issue":"3","key":"1110_CR16","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1097\/PAI.0b013e31815349f5","volume":"16","author":"SE Ten Heuvel","year":"2008","unstructured":"Ten Heuvel SE, Hoekstra HJ, Suurmeijer AJ. Diagnostic accuracy of FISH and RT-PCR in 50 routinely processed synovial sarcomas. Appl Immunohistochem Mol Morphol. 2008;16(3):246\u201350. https:\/\/doi.org\/10.1097\/PAI.0b013e31815349f5.","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"1","key":"1110_CR17","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/ajco.12980","volume":"15","author":"AC Vargas","year":"2019","unstructured":"Vargas AC, Selinger C, Satgunaseelan L, Cooper WA, Gupta R, Stalley P, et al. FISH analysis of selected soft tissue tumors: diagnostic experience in a tertiary center. Asia Pac J Clin Oncol. 2019;15(1):38\u201347. https:\/\/doi.org\/10.1111\/ajco.12980.","journal-title":"Asia Pac J Clin Oncol"},{"issue":"12","key":"1110_CR18","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1097\/PAS.0b013e3181b7ed36","volume":"33","author":"A Jagdis","year":"2009","unstructured":"Jagdis A, Rubin BP, Tubbs RR, Pacheco M, Nielsen TO. Prospective evaluation of TLE1 as a diagnostic immunohistochemical marker in synovial sarcoma. Am J Surg Pathol. 2009;33(12):1743\u201351. https:\/\/doi.org\/10.1097\/PAS.0b013e3181b7ed36.","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"1110_CR19","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1097\/PAI.0b013e318279f9ee","volume":"21","author":"AL Valente","year":"2013","unstructured":"Valente AL, Tull J, Zhang S. Specificity of TLE1 expression in unclassified high-grade sarcomas for the diagnosis of synovial sarcoma. Appl Immunohistochem Mol Morphol. 2013;21(5):408\u201313. https:\/\/doi.org\/10.1097\/PAI.0b013e318279f9ee.","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"6","key":"1110_CR20","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1309\/AJCP45SSNAOPXYXU","volume":"135","author":"WC Foo","year":"2011","unstructured":"Foo WC, Cruise MW, Wick MR, Hornick JL. Immunohistochemical staining for TLE1 distinguishes synovial sarcoma from histologic mimics. Am J Clin Pathol. 2011;135(6):839\u201344. https:\/\/doi.org\/10.1309\/AJCP45SSNAOPXYXU.","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"1110_CR21","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s00428-010-0975-8","volume":"457","author":"A Matsuyama","year":"2010","unstructured":"Matsuyama A, Hisaoka M, Iwasaki M, Iwashita M, Hisanaga S, Hashimoto H. TLE1 expression in malignant mesothelioma. Virchows Arch. 2010;457(5):577\u201383. https:\/\/doi.org\/10.1007\/s00428-010-0975-8.","journal-title":"Virchows Arch"},{"issue":"7","key":"1110_CR22","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/modpathol.3800795","volume":"20","author":"PH Hartel","year":"2007","unstructured":"Hartel PH, Fanburg-Smith JC, Frazier AA, Galvin JR, Lichy JH, Shilo K, et al. Primary pulmonary and mediastinal synovial sarcoma: a clinicopathologic study of 60 cases and comparison with five prior series. Mod Pathol. 2007;20(7):760\u20139. https:\/\/doi.org\/10.1038\/modpathol.3800795.","journal-title":"Mod Pathol"},{"issue":"9","key":"1110_CR23","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1111\/pin.12976","volume":"70","author":"S Tahara","year":"2020","unstructured":"Tahara S, Kohara M, Honma K, Morii E. Detection of synovial sarcoma with an atypical fusion transcript by using SS18-SSX and SSX antibodies. Pathol Int. 2020;70(9):689\u201391. https:\/\/doi.org\/10.1111\/pin.12976.","journal-title":"Pathol Int"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-021-01110-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-021-01110-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-021-01110-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T17:02:53Z","timestamp":1623690173000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-021-01110-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,14]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1110"],"URL":"https:\/\/doi.org\/10.1186\/s13000-021-01110-6","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,14]]},"assertion":[{"value":"26 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Shinshu University Research Ethics Committee (No. 4870).Consent to Participate \/Consent for Publication: All patients in this study consented to their involvement.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"54"}}